{"id":1577,"name":"Catalio Capital Management","slug":"catalio-capital-management","website":"https://www.cataliocapital.com/","hqGeo":"Baltimore, MD","stageFocus":["Seed","Series A"],"sectorTags":["Healthcare"],"excludedSectors":["Consumer","Media"],"checkSizeMin":250000,"checkSizeMax":5000000,"thesisSummary":"Invests in companies developing breakthrough life sciences and healthcare innovations.","thesisNarrative":null,"logoUrl":null,"aumUsd":2000000000,"submissionUrl":null,"linkedinUrl":null,"twitterHandle":null,"portfolio":[{"companyName":"audicus","companyUrl":null,"stage":"Loan Repayment","sector":"Healthcare","investmentYear":2025,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"pillar biosciences","companyUrl":null,"stage":"Loan Repayment","sector":"Biotechnology","investmentYear":2025,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"paige","companyUrl":null,"stage":"M&A","sector":"Healthcare","investmentYear":2025,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"sickbay","companyUrl":null,"stage":"Loan Repayment","sector":"Healthcare","investmentYear":2025,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"dianthus","companyUrl":null,"stage":"IPO","sector":"Biotechnology","investmentYear":2024,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"arrivent","companyUrl":null,"stage":"IPO","sector":"Biotechnology","investmentYear":2024,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"ensoma","companyUrl":null,"stage":"Loan Repayment","sector":"Biotechnology","investmentYear":2024,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"haystack oncology","companyUrl":null,"stage":"Exit","sector":"Healthcare","investmentYear":2023,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"neumora","companyUrl":null,"stage":"IPO","sector":"Biotechnology","investmentYear":2023,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"pgdx","companyUrl":null,"stage":"Exit","sector":"Healthcare","investmentYear":2022,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"atai life sciences","companyUrl":null,"stage":"IPO","sector":"Biotechnology","investmentYear":2021,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"recursion","companyUrl":null,"stage":"IPO","sector":"Biotechnology","investmentYear":2021,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"compass","companyUrl":null,"stage":"IPO","sector":"Healthcare","investmentYear":2020,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"thrive sciences","companyUrl":null,"stage":"Exit","sector":"Healthcare","investmentYear":2020,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"freenome","companyUrl":null,"stage":"N/A","sector":"Healthcare","investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"hippocratic ai","companyUrl":null,"stage":"N/A","sector":"AI","investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"noetik","companyUrl":null,"stage":"N/A","sector":"N/A","investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"somethings","companyUrl":null,"stage":"N/A","sector":"N/A","investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"dna script","companyUrl":null,"stage":"N/A","sector":"Biotechnology","investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"protara therapeutics","companyUrl":null,"stage":"N/A","sector":"Biotechnology","investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"superluminal medicines","companyUrl":null,"stage":"N/A","sector":"Biotechnology","investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"thea ai","companyUrl":null,"stage":"N/A","sector":"AI","investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Catalio Credit Opportunities Fund I LP  (CIK 0001876547)","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"SEC Form D filing mentioning Catalio Capital Management","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Catalio Public Equities Offshore Fund, Ltd.  (CIK 0001825051)","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"SEC Form D filing mentioning Catalio Capital Management","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Catalio Structured Opportunities Offshore Fund II, LP  (CIK 0002004366)","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"SEC Form D filing mentioning Catalio Capital Management","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Catalio Structured Opportunities Fund II, LP  (CIK 0002004375)","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"SEC Form D filing mentioning Catalio Capital Management","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Catalio Public Equities Fund, LP  (CIK 0001818447)","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"SEC Form D filing mentioning Catalio Capital Management","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Catalio Structured Opportunities Fund I LP  (CIK 0001876547)","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"SEC Form D filing mentioning Catalio Capital Management","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"AVAVA","companyUrl":null,"stage":"financing round with equity plus debt","sector":"healthcare / medtech","investmentYear":null,"description":"medical aesthetics company focused on next-generation energy-based technologies","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Enveda","companyUrl":null,"stage":"Series E","sector":"biotech / AI drug discovery","investmentYear":null,"description":"clinical-stage biotechnology company using AI to discover medicines from life’s chemistry","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Evvy","companyUrl":null,"stage":"Series B","sector":"healthtech / women’s health","investmentYear":null,"description":"precision medicine platform for women’s health diagnostics and care","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Emalex Biosciences","companyUrl":null,"stage":null,"sector":"Biotech","investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"ZAP Surgical Systems","companyUrl":null,"stage":"financing round","sector":"medtech / surgical robotics","investmentYear":null,"description":"developer of non-invasive robotic brain surgery systems","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"bayesian health","companyUrl":null,"stage":"N/A","sector":"Healthcare","investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"beacon biosignals","companyUrl":null,"stage":"N/A","sector":"Healthcare","investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"cagepharma","companyUrl":null,"stage":"N/A","sector":"Biotechnology","investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"cartography","companyUrl":null,"stage":"N/A","sector":"N/A","investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"clasp therapeutics","companyUrl":null,"stage":"N/A","sector":"Biotechnology","investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"iambic","companyUrl":null,"stage":"N/A","sector":"N/A","investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"immunai","companyUrl":null,"stage":"N/A","sector":"Biotechnology","investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"insightec","companyUrl":null,"stage":"N/A","sector":"Healthcare","investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"lila sciences","companyUrl":null,"stage":"N/A","sector":"Biotechnology","investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"medra","companyUrl":null,"stage":"N/A","sector":"N/A","investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"octant bio","companyUrl":null,"stage":"N/A","sector":"Biotechnology","investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"pheast therapeutics","companyUrl":null,"stage":"N/A","sector":"Biotechnology","investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"visby medical","companyUrl":null,"stage":"N/A","sector":"Healthcare","investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null}],"partnerCount":10,"partners":[{"id":4324,"name":"Isaac Ro","title":"Partner","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/isaacro","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":4323,"name":"Sofia Marsaglia","title":"Director of Impact","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/sofia-marsaglia-35290a109","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":4326,"name":"Will Denehy","title":"Vice President","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/will-denehy-32278a4a","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":4327,"name":"Olga Maltseva","title":"Chief Operating Officer","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/olgamaltseva","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":4328,"name":"John Iucker","title":"General Partner","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/jiucker","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":4329,"name":"Ben Snedeker","title":"Co-Head of Public Equities","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/ben-snedeker-b4445aa4","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":4330,"name":"Diamantis Xylas","title":"Director of Research","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/diamantis-xylas-495937213","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":4325,"name":"Tom Brooks","title":"General Partner","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/tom-brooks-54722a10","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":4331,"name":"Sarah Saraiva","title":"Finance Director","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/sarah-saraiva-69879b40","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":1870,"name":"George Petrocheilos","title":"Co-Founder & Managing Partner","seniority":null,"focusTags":["Life Sciences","Healthtech"],"linkedinUrl":"https://www.linkedin.com/in/georgepetrocheilos","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]}],"funds":[],"activity":{"lastInvestmentYear":2025,"investmentsThisYear":0},"activityItems":[{"kind":"investment","title":"Invested in sickbay","url":null,"source":"portfolio records","occurredAt":"2025-06-30T00:00:00.000Z"},{"kind":"investment","title":"Invested in pillar biosciences","url":null,"source":"portfolio records","occurredAt":"2025-06-30T00:00:00.000Z"},{"kind":"investment","title":"Invested in paige","url":null,"source":"portfolio records","occurredAt":"2025-06-30T00:00:00.000Z"},{"kind":"investment","title":"Invested in audicus","url":null,"source":"portfolio records","occurredAt":"2025-06-30T00:00:00.000Z"},{"kind":"investment","title":"Invested in ensoma","url":null,"source":"portfolio records","occurredAt":"2024-06-30T00:00:00.000Z"},{"kind":"investment","title":"Invested in dianthus","url":null,"source":"portfolio records","occurredAt":"2024-06-30T00:00:00.000Z"},{"kind":"investment","title":"Invested in arrivent","url":null,"source":"portfolio records","occurredAt":"2024-06-30T00:00:00.000Z"},{"kind":"investment","title":"Invested in neumora","url":null,"source":"portfolio records","occurredAt":"2023-06-30T00:00:00.000Z"}],"contentUpdatedAt":"2026-11-17T05:49:16.943Z","investorType":"vc","preferredApproach":"warm intro preferred","prefersFounderType":null,"oneClickPitchEnabled":false,"relatedFirms":[{"id":11323,"name":"Mountain Pine Capital","slug":"mountain-pine-capital","logoUrl":null,"website":"https://mountainpineholdings.com/","stageFocus":["Seed"],"sectorTags":["Consumer","Healthcare","Real Estate"],"hqGeo":"Salt Lake City, UT"},{"id":1621,"name":"Canary","slug":"canary","logoUrl":null,"website":"https://www.canary.capital/","stageFocus":["Pre-Seed","Seed"],"sectorTags":["Fintech","AI / ML","SaaS","Healthcare","Enterprise"],"hqGeo":"São Paulo, Brazil"},{"id":12955,"name":"Jovono","slug":"jovono","logoUrl":null,"website":"https://jovono.com","stageFocus":["Seed","Series A"],"sectorTags":["Climate / Energy","Fintech","Consumer","SaaS","Healthcare"],"hqGeo":"Los Angeles, CA"},{"id":12160,"name":"Solid Ventures","slug":"solid-ventures","logoUrl":null,"website":"https://www.solidventures.vc/","stageFocus":["Seed"],"sectorTags":["Fintech","Healthcare","SaaS","Enterprise","Developer Tools","Consumer"],"hqGeo":"Austin, TX"},{"id":13026,"name":"Robin Capital","slug":"robin-capital","logoUrl":null,"website":"https://robincap.com/","stageFocus":["Pre-Seed","Seed"],"sectorTags":["AI / ML","Fintech","SaaS","Climate / Energy","Healthcare"],"hqGeo":"Berlin, Germany"},{"id":12096,"name":"TeleHealth Ventures","slug":"telehealth-ventures","logoUrl":null,"website":"https://telehealthventures.com","stageFocus":["Seed"],"sectorTags":["Healthcare"],"hqGeo":"Austin, TX"}],"featuredIn":[{"slug":"seed","displayName":"Seed Investors","pageType":"stage"},{"slug":"series-a","displayName":"Series A Investors","pageType":"stage"},{"slug":"healthcare","displayName":"Healthcare Investors","pageType":"industry"}],"fundraisingResources":[{"slug":"find-right-pre-seed-investors-b2b-saas","title":"How to Find the Right Pre-Seed Investors for Your B2B SaaS Startup"},{"slug":"investormatch-mcp-server-claude-chatgpt","title":"Your Investor List Now Lives Inside Claude and ChatGPT"},{"slug":"how-to-find-investors","title":"How to Find Investors: A VC's Playbook for Founders"}],"overviewNarrative":"Catalio Capital Management is a venture capital firm headquartered in Baltimore, MD. The firm invests in companies developing breakthrough life sciences and healthcare innovations. Catalio Capital Management focuses on the Life Sciences and Healthcare sectors and does not invest in Consumer or Media.\n\nThe firm typically participates in seed and series A stages with check sizes ranging from $250K to $5.0M. Catalio Capital Management has $2B in assets under management. Warm introductions are preferred. The firm is led by a team that includes George Petrocheilos, Co-Founder and Managing Partner with focus on Life Sciences and Healthtech, along with Isaac Ro, Sofia Marsaglia, Will Denehy, Olga Maltseva, John Iucker, Ben Snedeker, Diamantis Xylas, Tom Brooks, and Sarah Saraiva.","portfolioNarrative":"Catalio Capital Management has recorded investments in 46 portfolio companies. The firm's earliest recorded investment year is 2020 and most recent is 2025. Recorded investments include companies such as audicus, paige, pillar biosciences, sickbay, arrivent, dianthus, ensoma, haystack oncology, neumora, pgdx, atai life sciences, recursion, compass, thrive sciences, and AVAVA across Biotechnology, Healthcare, and related subsectors.\n\nMany of these companies have achieved liquidity events including IPOs for arrivent, dianthus, neumora, atai life sciences, recursion, and compass as well as exits for haystack oncology, pgdx, and thrive sciences. Additional transactions include loan repayments, M&A, and a financing round with equity plus debt.","seoTitle":null,"seoDescription":null,"lastVerifiedAt":"2026-07-14T01:42:04.211Z"}